Upstream Considerations For Biosimilar Development
Upstream Considerations For Biosimilar Development By Hunter Malanson, Staff Scientist, Field Applications; Mariana Curcio, Technical Sales Specialist; and Albert Cheong, Associate Director, Services & Product Application, Thermo Fisher Scientific Bioproduction Cell Culture Many of the early and costly steps of drug development can be eliminated with biosimilars, which offer several advantages to pharmaceutical companies exploring new strategies for increasing their presence in the market. Howe...
Hunter Malanson Mariana Curcio Albert Cheong Services Product Application Staff Scientist Field Applications
Source: pharmaceuticalonline.com